


HILO WAVE® is a hyaluronic acid-based biomaterial developed with proprietary DHC® (Dual Hyaluronic Acid Compound) technology. DHC® combines High-Molecular-Weight Hyaluronic Acid (H-HA) and Low-Molecular-Weight Hyaluronic Acid (L-HA) in a proprietary HA fusion structure.
With 24 mg of HA per cc and a total HA content of 48 mg per 2.0 mL syringe, HILO WAVE® is designed to support comprehensive skin remodeling and overall skin quality, while naturally enhancing facial volume.
What is HILO WAVE®?HILO WAVE® is a Grade 4 medical device / biomaterial graft and prosthesis featuring the proprietary DHC® technology.
The DHC® technology combines high- and low-molecular-weight HA to create a differentiated HA structure. HILO WAVE® is composed of H-HA and L-HA and is designed for skin remodeling across the full thickness of the skin, including the dermis.
Key FeaturesHyaluronic Acid (HA): 48 mgH-HA + L-HA
Packing Unit2.0 mL × 1 Syringe / Box
Procedure AreaEvery 3 months
Product ClassificationMedical Device (Grade 4)Biomaterial Graft and Prosthesis
Country of OriginRepublic of Korea

South Korea #201, J bldg., 271-6, Dapsimni-ro, Dongdaemun-gu, Seoul, Republic of Korea
Contact Person STARPHARMTEC